Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma
Open Access
- 28 November 2022
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (1) , 125-132
Abstract
The nutritional risk index (NRI), which is based on weight and albumin levels, is closely associated with the prognosis of many cancers. However, its prognostic value has not been investigated in patients with newly diagnosed multiple myeloma (NDMM). We aimed to assess the association between the NRI and survival outcomes in patients with NDMM. We retrospectively collected and analyzed clinical and laboratory data from patients with NDMM between 2005 and 2019 at our center. Patients were stratified into the high NRI (> 89) and low NRI (≤ 89) groups for prognostic analysis. The NRI and other variables were also explored to evaluate their prognostic value for overall survival (OS). A total of 638 patients diagnosed with NDMM were retrospectively included. Patients in the high NRI group had a significantly better median OS than those in the low NRI group (64 months vs 43 months, p < 0.001). In the multivariate analysis, a high NRI was shown to be an independent prognostic factor for OS (hazard ratio, 0.758; 95% confidence interval, 0.587–0.977; p = 0.033). Age, performance status, transplant status, and lactate dehydrogenase level were also independent prognostic factors for OS. In conclusion, our study demonstrates that the NRI is a simple and useful predictor of survival outcomes in patients with NDMM.Keywords
Funding Information
- National Natural Science Foundation (82100184)
This publication has 34 references indexed in Scilit:
- The Effect of Malnutrition on Patients Undergoing Elective Joint ArthroplastyThe Journal of Arthroplasty, 2013
- Obesity and Weight Loss at Presentation of Lung Cancer are Associated with Opposite Effects on SurvivalJournal of Surgical Research, 2011
- Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancerCancer Causes & Control, 2010
- The Diversity of Nutritional Status in Cancer: New InsightsThe Oncologist, 2010
- Nutritional Status and Information Needs of Medical Oncology Patients Receiving Treatment at an Australian Public HospitalNutrition and Cancer, 2010
- Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus GuidelinesMayo Clinic Proceedings, 2009
- Impact of age on survival after intensive therapy for multiple myeloma: a population‐based study by the Nordic Myeloma Study GroupBritish Journal of Haematology, 2006
- Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative CareJournal of Clinical Oncology, 2005
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980